Related Experiment Video
Updated: Jun 6, 2025
09:09
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
931
Hypertonic saline in acute decompensated heart failure (HSHF).
Shweta Agrawal1, Sunil Abhishek Batta2, Tarun Rao3
1Department of Cardiology, St. John's medical college and hospital, Bangalore, India.
Indian Heart Journal
|November 23, 2024
Summary
Hypertonic saline with furosemide shows promise for refractory heart failure patients. This approach led to faster decongestion without worsening kidney function, suggesting a potential new treatment option.
Area of Science:
- Cardiology
- Nephrology
- Pharmacology
Background:
- Refractory acute decompensated heart failure poses significant clinical challenges.
- Diuretic resistance is common in these patients, necessitating alternative therapeutic strategies.
Purpose of the Study:
- To evaluate the efficacy and safety of hypertonic saline solution (HSS) combined with high-dose furosemide in patients with diuretic-resistant acute decompensated heart failure.
- To compare the outcomes of HSS with furosemide versus furosemide alone in this patient population.
Main Methods:
- A case series involving 10 patients with refractory acute decompensated heart failure.
- Comparison of treatment response between HSS plus furosemide and furosemide monotherapy.
Main Results:
- Patients receiving HSS with furosemide demonstrated improved response.
- Faster decongestion was observed in the HSS group.
- No significant adverse effects or deterioration in renal function were noted.
Conclusions:
- Hypertonic saline with furosemide appears to be a promising option for managing refractory acute decompensated heart failure.
- Further adequately powered randomized studies are warranted to confirm these findings.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
343
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
343
01:26Heart Failure Drugs: Inotropic Agents
521
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
521
01:16Tonicity in Animals
3.0K
Tonicity describes the amount of solute in a solution. The measure of the tonicity of a solution, or the total amount of solutes dissolved in a specific amount of solution, is called its osmolarity. Three terms—hypotonic, isotonic, and hypertonic—are used to relate the osmolarity of a cell to the osmolarity of the extracellular fluid that contains the cells. In a hypotonic solution, such as tap water, the extracellular fluid has a lower concentration of solutes than the fluid inside...
3.0K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
01:28Mitral Regurgitation IV: Nursing Management
3
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
3
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
455
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
455